Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron P Vaughn
Alexander Khoruts

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
The American Journal of Gastroenterology|September 4, 2024
Diagnosis and Management of Clostridioides difficile in Inflammatory Bowel DiseaseByron P Vaughn, Alexander Khoruts, Monika Fischer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2018
Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver DiseaseByron P Vaughn, Kevin M Rank, Alexander Khoruts
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2019
Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America GuidelinesRadha Rajasingham, Eva A Enns, Alexander Khoruts, et al.
Gut Microbes|January 20, 2017
Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel diseaseKrista M Newman, Kevin M Rank, Byron P Vaughn, et al.
Gut Microbes|April 14, 2025
Metagenomic source tracking after microbiota transplant therapySusan L Hoops, Daphne Moutsoglou, Byron P Vaughn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2026
Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionWilliam Hirsch, Eva A Enns, Alexander Khoruts, et al.
Inflammatory Bowel Diseases|June 23, 2026
Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trialDaphne Moutsoglou, Christopher Staley, Amanda J Kabage, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infectionChristopher Staley, Byron P Vaughn, Carolyn T Graiziger, et al.
Nutrients|April 28, 2019
Dietary Factors in Sulfur Metabolism and Pathogenesis of Ulcerative ColitisLevi M Teigen, Zhuo Geng, Michael J Sadowsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 25, 2016
Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile InfectionAlexander Khoruts, Kevin M Rank, Krista M Newman, et al.
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
The American Journal of Gastroenterology|September 4, 2024
Diagnosis and Management of Clostridioides difficile in Inflammatory Bowel DiseaseByron P Vaughn, Alexander Khoruts, Monika Fischer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2018
Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver DiseaseByron P Vaughn, Kevin M Rank, Alexander Khoruts
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2019
Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America GuidelinesRadha Rajasingham, Eva A Enns, Alexander Khoruts, et al.
Gut Microbes|January 20, 2017
Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel diseaseKrista M Newman, Kevin M Rank, Byron P Vaughn, et al.
Gut Microbes|April 14, 2025
Metagenomic source tracking after microbiota transplant therapySusan L Hoops, Daphne Moutsoglou, Byron P Vaughn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2026
Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionWilliam Hirsch, Eva A Enns, Alexander Khoruts, et al.
Inflammatory Bowel Diseases|June 23, 2026
Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trialDaphne Moutsoglou, Christopher Staley, Amanda J Kabage, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infectionChristopher Staley, Byron P Vaughn, Carolyn T Graiziger, et al.
Nutrients|April 28, 2019
Dietary Factors in Sulfur Metabolism and Pathogenesis of Ulcerative ColitisLevi M Teigen, Zhuo Geng, Michael J Sadowsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 25, 2016
Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile InfectionAlexander Khoruts, Kevin M Rank, Krista M Newman, et al.
Pageof 20